Instituto de Cardiologia do Rio Grande do Sul

Porto Alegre, Rio Grande do Sul 90620-001

0 studies enrolling now · 6 studies all time

What they study most

Amyloid Cardiomyopathy, Transthyretin-Related, Atherosclerotic Cardiovascular Disease, COVID-19, Cardiovascular Disease, Coronary Revascularization, Myocardial Infarction, Pneumonia, Stroke, Thrombosis

Studies at this site

• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
• A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
• Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants — Running, not enrolling
• EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction — Running, not enrolling
• A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation — Completed
• Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) — Completed